|
MCE 国际站:Loncastuximab
CAS:1875032-68-0
品牌:MedChemExpress (MCE)
存储条件:Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性:Loncastuximab (RB4v1.2) 是一种抗 CD19 单克隆抗体。Loncastuximab 展现出抗肿瘤性,在非霍奇金淋巴瘤 (NHL) 包括弥漫性大 B 细胞淋巴瘤 (DLBCL) 中也有潜在的应用。
热销产品:Lucifer Yellow CH (dipotassium salt) | G140 | CX-5461 | SAR405 | Fostamatinib | E 2012 | Sunvozertinib | CRT0066101 (dihydrochloride) | Birabresib | BiP inducer X
作用靶点:CD19
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
参考文献:[1]. Zinzani PL, et al. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2022 Jan;148(1):177-190.
[2]. Hess B, et al. Efficacy and Safety Exposure-Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma. AAPS J. 2021 Dec 10;24(1):11.
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-8-7 13:26
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社